Tag - TRIB

Developments

Trinity achieves breakthrough trial results for next-gen CGM sensor

Trinity Biotech (NASDAQ: TRIB) has announced compelling clinical trial results demonstrating a major technical breakthrough and de-risking the commercial pathway for its next-generation continuous glucose monitoring...

August 12, 2025

Developments

Trinity Biotech unveils new microsite to highlight distinctive technology and AI-driven platform

Trinity Biotech (NASDAQ: TRIB) has announced the launch of its continuous glucose monitoring (CGM) microsite to provide insights into the development of its next-generation CGM biosensor technology and AI-driven health...

June 3, 2024

Tag - TRIB

Trinity achieves breakthrough trial results for next-gen CGM sensor

Trinity Biotech unveils new microsite to highlight distinctive technology and AI-driven platform

Subscribe